Invention Grant
- Patent Title: Orally administering parathyroid hormone and calcitonin
- Patent Title (中): 口服甲状旁腺激素和降钙素
-
Application No.: US12020700Application Date: 2008-01-28
-
Publication No.: US08153587B2Publication Date: 2012-04-10
- Inventor: Joseph M Ault , Moise Azria , Simon D Bateman , James F McLeod
- Applicant: Joseph M Ault , Moise Azria , Simon D Bateman , James F McLeod
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent David R. Kurlandsky
- Main IPC: A61K38/29
- IPC: A61K38/29 ; A61K38/23 ; A61P5/18 ; C07K14/635 ; C07K14/585
Abstract:
A method for orally administering a parathyroid hormone, PTH, comprising orally co-administering to a patient in need of PTH an effective amount of a PTH and an effective amount of calcitonin. The method according to the invention allows for the oral administration of PTH without the hypercalcemia, hypercalcuria and nephrolithiasis side effects.
Public/Granted literature
- US20080119411A1 ORALLY ADMINISTERING PARATHYROID HORMONE AND CALCITONIN Public/Granted day:2008-05-22
Information query
IPC分类:
